Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial.
Authors: Balevic SJ; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina., Benjamin DK Jr; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina., Powderly WG; Division of Infectious Diseases, Department of Medicine, Washington University in St Louis, St Louis, Missouri., Smith PB; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina., Gonzalez D; Duke Clinical Research Institute, Durham, North Carolina., McCarthy MW; Department of Medicine, Weill Cornell Medicine, New York, New York., Shaw LK; Duke Clinical Research Institute, Durham, North Carolina., Lindsell CJ; Duke Clinical Research Institute, Durham, North Carolina., Bozzette S; National Center for Advancing Translational Sciences, Bethesda, Maryland., Williams D; Bristol Myers Squibb, Philadelphia, Pennsylvania., Linas BP; Section of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts., Blamoun J; Department of Critical Care, MyMichigan Health, Midland., Javeri H; Division of Infectious Diseases, Department of Medicine, University of Texas Health Science Center, San Antonio., Hornik CP; Duke Clinical Research Institute, Durham, North Carolina.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina.
Corporate Authors: ACTIV-1 IM Study Group
Source: JAMA network open [JAMA Netw Open] 2024 Apr 01; Vol. 7 (4), pp. e247615. Date of Electronic Publication: 2024 Apr 01.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2574-3805
DOI:10.1001/jamanetworkopen.2024.7615